Brain-computer interfaces could change the world—but at what cost?
Dr. Andrew Ko and Dr.
Research and Innovation
New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows
Dr. Andrew Ko is part of a research team that has developed a test to measure levels of amyloid beta oligomers in blood samples. Oligomers are amyloid beta proteins that misfold and clump together potentially developing into Alzheimer’s.
EVOLVE Study Shows Minor Head Injuries Can Have Lasting Effects
Dr. Christine Mac Donald’s long-running study of U.S. military service members (EVOLVE) shows that many who sustained mild traumatic brain injuries (TBIs) from combat-related explosions continue to feel adverse effects for years afterward.
It’s time to meet the future of the OR: Collaborators
Dr. Sam Browd discusses how leveraging AI technology may lead to improving patient outcomes, making care more accessible and reducing costs across the board.
AVMs the Subject of Neurosurgical Focus July Issue
The Department’s own Louis J Kim, MD, MBA served as lead editor of The Journal of Neurosurgery’s July issue of Neurosurgical Focus. And, a team of our residents and faculty –
Jeffrey Ojemann, MD receives $8 million NIH grant
Congratulations to Dr. Ojemann whose proposal “Motor Recovery through Plasticity-Inducing Cortical Stimulation” has received grant in the amount of $8,000,000 from the National Institute Of Neurological Disorders And Stroke (NINDS) of the National Institutes of Health.
Epilepsy patients undergoing surgery provide valuable tactile sensation feedback
The team at the University of Washington’s Center for Neurotechnology is working out how best to engineer stimulation to the brain to restore tactile sensations that allow people to perform useful tasks.
How a game-changing transplant could treat dying organs
Scientists and doctors including Dr. Melanie Walker and Dr. Michael Levitt are exploring the use mitochondria infusions to jump-start the cellular processes required to heal damaged hearts, brains, and maybe even other organs in a way that drugs haven’t been able to.
Kate Carroll, MD selected to receive NIH R-25 Grant to study depression associated with aneurysmal subarachnoid hemorrhage
Congratulations to Dr. Carroll whose proposal “The role of CRHR1 genotype and hypothalamic-pituitary-adrenal axis dysfunction in depression after aneurysm rupture” was selected to receive an NIH R-25 award totaling $95,139, beginning July 1, 2022.